• From RUNX2 to Reliable Samples: Translational Rigor

  2026-09-28

  A translational perspective on connecting osteoblast mechanism studies with disciplined blood sample preparation. Learn what the trelagliptin–RUNX2 findings establish, where their limits remain, and how selective erythrocyte removal can support separate downstream analyses.

• Hyaluronic Acid Sodium Salt for siRNA Research

  2026-09-27

  Explore how high-molecular-weight hyaluronic acid can support extracellular-matrix assays and nanoparticle delivery research, informed by a preclinical study of siRNA treatment for Pseudomonas aeruginosa lung injury. The workflow emphasizes formulation checks, matched controls, and clear separation between published findings and proposed pilot conditions.

• D-Luciferin Potassium Salt for Imaging Workflows

  2026-09-26

  D-Luciferin potassium salt supports firefly luciferase readouts in live-cell assays, ATP measurements, and in vivo bioluminescence imaging. This guide connects practical assay design to a cotton plant-defense study while clarifying what a luciferase signal can—and cannot—tell you.

• 4-Phenylbutyric Acid for ER Stress and Autophagy Assays

  2026-09-25

  Use 4-PBA as a mechanistic rescue tool to test whether ER stress contributes to compound-induced cell death—not as a stand-alone proof of pathway involvement. This workflow connects a liver-cancer study of cytotoxic autophagy to practical dose selection, matched-solvent controls, and orthogonal readouts.

• EZ Cap™ Firefly Luciferase mRNA for LNP Assays

  2026-09-25

  Use this Cap 1 reporter to separate mRNA delivery and translation from promoter-driven transcription in cell assays. Its strongest value is comparative: it can help rank delivery conditions in vitro, while recent LNP research shows why those rankings still need careful validation in vivo.

• CCK-8 Assays for Lung Cancer Research

  2026-09-24

  Use Cell Counting Kit-8 to track viable-cell metabolic activity during lung cancer experiments, from CCT3 perturbation studies to dose-response testing. A practical 96-well workflow, controls, and troubleshooting tips help distinguish real growth effects from assay interference.

• CD300LD-Targeted mRNA Vaccines Activate Tumor Neutrophils

  2026-09-24

  A 2026 study reports a biomimetic mRNA nanovaccine designed to target CD300LD-expressing tumor-associated neutrophils and sustain their activation through IL-36γ expression. In mouse hepatocellular carcinoma models, the formulation was associated with stronger antitumor immunity and a reported survival rate of 85% in the treated group, while key translational questions remain open.

• Fzd4 N-Glycosylation Enables Wnt/β-Catenin Signaling

  2026-09-23

  Ji and colleagues identify two conserved N-glycosylation sites in Fzd4 and show that glycosylation supports receptor maturation, stability, cell-surface transport, and signaling. Their findings connect this post-translational modification to NSCLC cell growth and migration, while highlighting receptor processing as an important variable in studies of Wnt signaling.

• Sulfo-NHS-SS-Biotin for Dynamic Protein Assays

  2026-09-23

  Sulfo-NHS-SS-Biotin combines aqueous amine labeling with a cleavable disulfide spacer for reversible protein enrichment. This article connects its assay logic to new structural and single-molecule insights into the rice vacuolar phosphate transporter OsVPE2.

• (Z)-4-Hydroxytamoxifen in Relapse Models

  2026-09-22

  Use (Z)-4-Hydroxytamoxifen to interrogate estrogen receptor signaling with high-affinity pharmacology, then connect those findings to proliferation, dormancy, and relapse biology. This workflow distinguishes ER-dependent drug response from the low-cycling tumor reservoirs revealed by modern transgenic relapse models.

• Shrimp STING and the Evolution of DNA Sensing

  2026-09-22

  This study shows that Litopenaeus vannamei STING can directly recognize double-stranded DNA as well as cyclic dinucleotides and activate an IFN-like antiviral program. Its evidence defines a dsDNA–STING–IKKε–IRF–Vago4 axis in an arthropod, extending current models of how cytosolic nucleic-acid sensing evolved.

• OATP1B3 N-Glycosylation and Surface Expression

  2026-09-21

  A 2024 study mapped six N-glycosylation sites on hepatic OATP1B3 and showed that this transporter is more extensively glycosylated than the closely related OATP1B1. The work connects glycan loss to endoplasmic-reticulum retention, reduced plasma-membrane expression, and lower transport turnover, providing a mechanistic framework for interpreting OATP1B3 dysfunction.

• ddhCTP in RNA Virus Replication Assays

  2026-09-21

  ddhCTP is a direct chain-termination probe for studying viral RNA polymerases, complementing cell-based antiviral experiments with a defined biochemical mechanism. This workflow shows how to use it in RdRp assays, HEK293T cell antiviral assays, and mechanistic studies that distinguish metabolite activity from broader viperin functions.

• Aumolertinib Plus Radiation in EGFR-Mutant Brain Metastases

  2026-09-20

  The reference study integrates an intracranial xenograft model, cellular assays, pharmacokinetic analysis, and a clinical case to examine aumolertinib with ionizing radiation in EGFR-mutant NSCLC brain metastases. Its findings support enhanced antitumor activity, greater intracranial aumolertinib accumulation, impaired DNA-damage repair, and increased apoptosis, while remaining preliminary for clinical translation.

• From m6A Mechanism to Translational RNA Assays

  2026-09-19

  A translational framework for converting new insight into the METTL14–SMN axis into disciplined RNA-binding, interaction, and patient-model experiments using biotinylated RNA substrates.

654 records 1/44 page Next 12345 下5页 Last page